{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:13:14Z","timestamp":1790979194331,"version":"4.1.0"},"reference-count":268,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004515","name":"Centre for Research and Instrumentation Management (CRIM), Universiti Kebangsaan Malaysia","doi-asserted-by":"publisher","award":["DIP-2024-005"],"award-info":[{"award-number":["DIP-2024-005"]}],"id":[{"id":"10.13039\/501100004515","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cardiovascular diseases (CVDs), including heart failure (HF), hypertension, myocardial infarction (MI), and atherosclerosis, are increasingly linked to gut microbiota dysbiosis and its metabolic byproducts. HF, affecting over 64 million individuals globally, is associated with systemic inflammation and gut barrier dysfunction, exacerbating disease progression. Similarly, hypertension and MI correlate with reduced microbial diversity and an abundance of pro-inflammatory bacteria, contributing to vascular inflammation and increased cardiovascular risk. Atherosclerosis is also influenced by gut dysbiosis, with key microbial metabolites such as trimethylamine-N-oxide (TMAO) and short-chain fatty acids (SCFAs) playing crucial roles in disease pathogenesis. Emerging evidence highlights the therapeutic potential of natural compounds, including flavonoids, omega-3 fatty acids, resveratrol, curcumin, and marine-derived bioactives, which modulate the gut microbiota and confer cardioprotective effects. These insights underscore the gut microbiota as a critical regulator of cardiovascular health, suggesting that targeting dysbiosis may offer novel preventive and therapeutic strategies. Further research is needed to elucidate underlying mechanisms and optimize microbiome-based interventions for improved cardiovascular outcomes.<\/jats:p>","DOI":"10.3390\/ijms26094264","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:50:17Z","timestamp":1745992217000},"page":"4264","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Gut Microbiota and Cardiovascular Diseases: Unraveling the Role of Dysbiosis and Microbial Metabolites"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8861-2786","authenticated-orcid":false,"given":"Barathan","family":"Muttiah","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4859-1439","authenticated-orcid":false,"given":"Alfizah","family":"Hanafiah","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Immunology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia"},{"name":"GUT Research Group, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.mayocpiqo.2023.08.005","article-title":"The Burden of Chronic Disease","volume":"8","author":"Hacker","year":"2024","journal-title":"Mayo Clin. Proc. Innov. Qual. Outcomes"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5334\/gh.1288","article-title":"The Heart of the World","volume":"19","author":"Perel","year":"2024","journal-title":"Glob. Heart"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"ref_4","unstructured":"GBD Chronic Respiratory Disease Collaborators (2020). Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med., 8, 585\u2013596."},{"key":"ref_5","unstructured":"GBD 2021 Diabetes Collaborators (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet, 402, 203\u2013234."},{"key":"ref_6","first-page":"46958020927885","article-title":"Noncommunicable Diseases Prevention In Low- and Middle-Income Countries: An Overview of Health in All Policies (HiAP)","volume":"58","author":"Ndubuisi","year":"2021","journal-title":"Inq. A J. Med. Care Organ. Provis. Financ."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"NCD Countdown 2030 collaborators (2018). NCD Countdown 2030: Worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet, 392, 1072\u20131088.","DOI":"10.1016\/S0140-6736(18)31992-5"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Budreviciute, A., Damiati, S., Sabir, D.K., Onder, K., Schuller-Goetzburg, P., Plakys, G., Katileviciute, A., Khoja, S., and Kodzius, R. (2020). Management and Prevention Strategies for Non-communicable Diseases (NCDs) and Their Risk Factors. Front. Public Health, 8.","DOI":"10.3389\/fpubh.2020.574111"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1365-3156.2008.02116.x","article-title":"Non-communicable diseases in low- and middle-income countries: Context, determinants and health policy","volume":"13","author":"Miranda","year":"2008","journal-title":"Trop. Med. Int. Health"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.mpaic.2022.05.004","article-title":"Challenges in healthcare delivery in low- and middle-income countries","volume":"23","author":"Phelan","year":"2022","journal-title":"Anaesth. Intensiv. Care Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"010304","DOI":"10.7189\/jogh.06.010304","article-title":"Addressing the growing burden of non-communicable disease by leveraging lessons from infectious disease management","volume":"6","author":"Piot","year":"2016","journal-title":"J. Glob. Health"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","article-title":"Unveiling the mechanisms and challenges of cancer drug resistance","volume":"22","author":"Khan","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12967-022-03296-9","article-title":"Microbiota medicine: Towards clinical revolution","volume":"20","author":"Gebrayel","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kandpal, M., Indari, O., Baral, B., Jakhmola, S., Tiwari, D., Bhandari, V., Pandey, R.K., Bala, K., Sonawane, A., and Jha, H.C. (2022). Dysbiosis of Gut Microbiota from the Perspective of the Gut-Brain Axis: Role in the Provocation of Neurological Disorders. Metabolites, 12.","DOI":"10.3390\/metabo12111064"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.31557\/APJCP.2019.20.1.5","article-title":"A Review of Gastric Cancer Research in Malaysia","volume":"20","author":"Lim","year":"2019","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.2147\/IDR.S219069","article-title":"Molecular characterization and prevalence of antibiotic resistance in Helicobacter pylori isolates in Kuala Lumpur, Malaysia","volume":"12","author":"Hanafiah","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1469-0691.2009.03035.x","article-title":"Hepatitis B and C virus-related carcinogenesis","volume":"15","author":"Fung","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Barathan, M., Mohamed, R., Yong, Y.K., Kannan, M., Vadivelu, J., Saeidi, A., Larsson, M., and Shankar, E.M. (2018). Viral Persistence and Chronicity in Hepatitis C Virus Infection: Role of T-Cell Apoptosis, Senescence and Exhaustion. Cells, 7.","DOI":"10.20944\/preprints201810.0033.v1"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s12026-014-8496-1","article-title":"The interplay between Epstein-Barr virus and B lymphocytes: Implications for infection, immunity, and disease","volume":"58","author":"Hatton","year":"2014","journal-title":"Immunol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and Cancer: Triggers, Mechanisms, and Consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1002\/mco2.171","article-title":"Gut and obesity\/metabolic disease: Focus on microbiota metabolites","volume":"3","author":"Lin","year":"2022","journal-title":"MedComm"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10620-020-06090-z","article-title":"Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases","volume":"65","author":"Oka","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Plamada, D., and Vodnar, D.C. (2021). Polyphenols-Gut Microbiota Interrelationship: A Transition to a New Generation of Prebiotics. Nutrients, 14.","DOI":"10.3390\/nu14010137"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Sorrenti, V., Bur\u00f2, I., Consoli, V., and Vanella, L. (2023). Recent Advances in Health Benefits of Bioactive Compounds from Food Wastes and By-Products: Biochemical Aspects. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032019"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Ogunrinola, G.A., Oyewale, J.O., Oshamika, O.O., and Olasehinde, G.I. (2020). The Human Microbiome and Its Impacts on Health. Int. J. Microbiol., 2020.","DOI":"10.1155\/2020\/8045646"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/MIB.0000000000000750","article-title":"Current Understanding of Dysbiosis in Disease in Human and Animal Models","volume":"22","author":"DeGruttola","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health","volume":"80","author":"Vaduganathan","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1007\/s10482-020-01474-7","article-title":"Human gut microbiota\/microbiome in health and diseases: A review","volume":"113","author":"Gomaa","year":"2020","journal-title":"Antonie Leeuwenhoek"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Afzaal, M., Saeed, F., Shah, Y.A., Hussain, M., Rabail, R., Socol, C.T., Hassoun, A., Pateiro, M., Lorenzo, J.M., and Rusu, A.V. (2022). Human gut microbiota in health and disease: Unveiling the relationship. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.999001"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Y\u00fcksel, E., Voragen, A.G.J., and Kort, R. (2024). The pectin metabolizing capacity of the human gut microbiota. Crit. Rev. Food Sci. Nutr., 1\u201323.","DOI":"10.1080\/10408398.2024.2400235"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12602-024-10370-9","article-title":"Exploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm","volume":"17","author":"Tufail","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Petakh, P., Oksenych, V., and Kamyshnyi, A. (2023). The F\/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin. Biomed. Pharmacother., 163.","DOI":"10.1016\/j.biopha.2023.114892"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1093\/advances\/nmy063","article-title":"Mechanisms of Action of Probiotics","volume":"10","author":"Gil","year":"2019","journal-title":"Adv. Nutr."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Moon, C.D., Young, W., Maclean, P.H., Cookson, A.L., and Bermingham, E.N. (2018). Metagenomic insights into the roles of Proteobacteria in the gastrointestinal microbiomes of healthy dogs and cats. MicrobiologyOpen, 7.","DOI":"10.1002\/mbo3.677"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Zhang, P. (2022). Influence of Foods and Nutrition on the Gut Microbiome and Implications for Intestinal Health. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23179588"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Fu, J., Zheng, Y., Gao, Y., and Xu, W. (2022). Dietary Fiber Intake and Gut Microbiota in Human Health. Microorganisms, 10.","DOI":"10.3390\/microorganisms10122507"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Shin, Y., Han, S., Kwon, J., Ju, S., Choi, T.G., Kang, I., and Kim, S.S. (2023). Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease. Nutrients, 15.","DOI":"10.3390\/nu15204466"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Sejbuk, M., Miro\u0144czuk-Chodakowska, I., Karav, S., and Witkowska, A.M. (2024). Dietary Polyphenols, Food Processing and Gut Microbiome: Recent Findings on Bioavailability, Bioactivity, and Gut Microbiome Interplay. Antioxidants, 13.","DOI":"10.3390\/antiox13101220"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Leeuwendaal, N.K., Stanton, C., O\u2019Toole, P.W., and Beresford, T.P. (2022). Fermented Foods, Health and the Gut Microbiome. Nutrients, 14.","DOI":"10.3390\/nu14071527"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Strasser, B., Wolters, M., Weyh, C., Kr\u00fcger, K., and Ticinesi, A. (2021). The Effects of Lifestyle and Diet on Gut Microbiota Composition, Inflammation and Muscle Performance in Our Aging Society. Nutrients, 13.","DOI":"10.3390\/nu13062045"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/NHA-170030","article-title":"Gut microbiome and aging: Physiological and mechanistic insights","volume":"4","author":"Nagpal","year":"2018","journal-title":"Nutr. Healthy Aging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3831972","DOI":"10.1155\/2017\/3831972","article-title":"Exercise Modifies the Gut Microbiota with Positive Health Effects","volume":"2017","author":"Monda","year":"2017","journal-title":"Oxidative Med. Cell Longev."},{"key":"ref_45","first-page":"163","article-title":"Alcohol and Gut-Derived Inflammation","volume":"38","author":"Bishehsari","year":"2017","journal-title":"Alcohol Res. Curr. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","article-title":"Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified","volume":"25","author":"Bruno","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"114400","DOI":"10.1016\/j.addr.2022.114400","article-title":"Microbiome as an immune regulator in health, disease, and therapeutics","volume":"188","author":"Juarez","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Bora, S.S., Gogoi, R., Sharma, M.R., Anshu Borah, M.P., Deka, P., Bora, J., Naorem, R.S., Das, J., and Teli, A.B. (2024). Microplastics and human health: Unveiling the gut microbiome disruption and chronic disease risks. Front. Cell. Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1492759"},{"key":"ref_49","first-page":"541","article-title":"Early-life exposures and the microbiome: Implications for IBD prevention","volume":"73","author":"Zhang","year":"2024","journal-title":"Gut"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Ojeda-Granados, C., Campisi, E., Barchitta, M., and Agodi, A. (2024). Genetic, lifestyle and metabolic factors contributing to cardiovascular disease in the Italian population: A literature review. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1379785"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","article-title":"Gut Microbiota in Cardiovascular Health and Disease","volume":"120","author":"Tang","year":"2017","journal-title":"Circ. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/1751-7915.13524","article-title":"The gut microbiota and its interactions with cardiovascular disease","volume":"13","author":"Xu","year":"2020","journal-title":"Microb. Biotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global Public Health Burden of Heart Failure: An Updated Review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: A policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ. Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4330\/wjc.v12.i8.373","article-title":"Sympathetic nervous system activation and heart failure: Current state of evidence and the pathophysiology in the light of novel biomarkers","volume":"12","author":"Borovac","year":"2020","journal-title":"World J. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000447252","article-title":"Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation?","volume":"1","author":"Fukui","year":"2016","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_57","first-page":"e67010","article-title":"Gut Dysbiosis and Cardiovascular Health: A Comprehensive Review of Mechanisms and Therapeutic Potential","volume":"16","author":"Trehan","year":"2024","journal-title":"Cureus"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez-Bail\u00f3n, M., Jim\u00e9nez-Garc\u00eda, R., Hern\u00e1ndez-Barrera, V., Miguel-D\u00edez, J., Miguel-Yanes, J.M., Mu\u00f1oz-Rivas, N., Lorenzo-Villalba, N., Carabantes-Alarcon, D., Zamorano-Le\u00f3n, J.J., and Astasio-Arbiza, P. (2020). Heart Failure Is a Risk Factor for Suffering and Dying of Clostridium difficile Infection. Results of a 15-Year Nationwide Study in Spain. J. Clin. Med., 9.","DOI":"10.3390\/jcm9030614"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Duan, H., Wang, L., Huangfu, M., and Li, H. (2023). The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials. Biomed. Pharmacother., 165.","DOI":"10.1016\/j.biopha.2023.115276"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Patil, R.S., Maloney, M.E., Lucas, R., Fulton, D.J.R., Patel, V., Bagi, Z., Kovacs-Kasa, A., Kovacs, L., Su, Y., and Verin, A.D. (2024). Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology. Biomolecules, 14.","DOI":"10.20944\/preprints202401.0165.v1"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","article-title":"Intersections Between Microbiome and Heart Failure: Revisiting the Gut Hypothesis","volume":"21","author":"Nagatomo","year":"2015","journal-title":"J. Card. Fail."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.31083\/j.rcm2507240","article-title":"Role of Trimethylamine N-Oxide in Heart Failure","volume":"25","author":"Jing","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Palm, C.L., Nijholt, K.T., Bakker, B.M., and Westenbrink, B.D. (2022). Short-Chain Fatty Acids in the Metabolism of Heart Failure\u2014Rethinking the Fat Stigma. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.915102"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tcm.2012.07.003","article-title":"PGC-1 proteins and heart failure","volume":"22","author":"Riehle","year":"2012","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Li, Y., Wang, L., Yi, Q., Luo, L., and Xiong, Y. (2024). Regulation of bile acids and their receptor FXR in metabolic diseases. Front. Nutr., 11.","DOI":"10.3389\/fnut.2024.1447878"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1111\/jcmm.13759","article-title":"Branched-chain amino acids promote endothelial dysfunction through increased reactive oxygen species generation and inflammation","volume":"22","author":"Zhenyukh","year":"2018","journal-title":"J. Cell Mol. Med."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Li, S. (2023). Modulation of immunity by tryptophan microbial metabolites. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1209613"},{"key":"ref_68","first-page":"3691","article-title":"Maintaining PGC-1\u03b1 expression following pressure overload-induced cardiac hypertrophy preserves angiogenesis but not contractile or mitochondrial function","volume":"28","author":"Pereira","year":"2014","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Cianci, R., Franza, L., Borriello, R., Pagliari, D., Gasbarrini, A., and Gambassi, G. (2022). The Role of Gut Microbiota in Heart Failure: When Friends Become Enemies. Biomedicines, 10.","DOI":"10.3390\/biomedicines10112712"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2023.02.045","article-title":"Gut Microbiome-Based Management of Patients With Heart Failure: JACC Review Topic of the Week","volume":"81","author":"Mamic","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"102128","DOI":"10.1016\/j.cpcardiol.2023.102128","article-title":"Recent advances on the Role of Gut Microbiota in the Development of Heart Failure by Mediating Immune Metabolism","volume":"49","author":"Huang","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5491838","DOI":"10.1155\/2017\/5491838","article-title":"Prevalence and Associated Risk Factors of Hypertension: A Cross-Sectional Study in Urban Varanasi","volume":"2017","author":"Singh","year":"2017","journal-title":"Int. J. Hypertens"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","article-title":"Prevalence, awareness, treatment, and control of hypertension in China: Data from 1\u00b77 million adults in a population-based screening study (China PEACE Million Persons Project)","volume":"390","author":"Lu","year":"2017","journal-title":"Lancet"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Yang, Z., Lin, S., Liu, Y., Song, Z., Ge, Z., Fan, Y., Chen, L., Bi, Y., Zhao, Z., and Wang, X. (2023). Targeting intestinal microecology: Potential intervention strategies of traditional Chinese medicine for managing hypertension. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1171119"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/jch.14722","article-title":"Gut microbiota changes in patients with hypertension: A systematic review and meta-analysis","volume":"25","author":"Cai","year":"2023","journal-title":"J. Clin. Hypertens"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Fusco, W., Lorenzo, M.B., Cintoni, M., Porcari, S., Rinninella, E., Kaitsas, F., Lener, E., Mele, M.C., Gasbarrini, A., and Collado, M.C. (2023). Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients, 15.","DOI":"10.3390\/nu15092211"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Verhaar, B.J.H., Prodan, A., Nieuwdorp, M., and Muller, M. (2020). Gut Microbiota in Hypertension and Atherosclerosis: A Review. Nutrients, 12.","DOI":"10.3390\/nu12102982"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Mousa, W.K., Chehadeh, F., and Husband, S. (2022). Microbial dysbiosis in the gut drives systemic autoimmune diseases. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.906258"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1007\/s00467-022-05802-z","article-title":"Endothelial dysfunction as a factor leading to arterial hypertension","volume":"38","year":"2023","journal-title":"Pediatr. Nephrol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Al Khodor, S., Reichert, B., and Shatat, I.F. (2017). The Microbiome and Blood Pressure:\u2009Can Microbes Regulate Our Blood Pressure?. Front. Pediatr., 5.","DOI":"10.3389\/fped.2017.00138"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","article-title":"Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease","volume":"20","author":"Violi","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s11864-024-01270-9","article-title":"Targeting the Renin\u2013angiotensin\u2013aldosterone System (RAAS) for Cardiovascular Protection and Enhanced Oncological Outcomes: Review","volume":"25","author":"Pawlonka","year":"2024","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.niox.2023.05.006","article-title":"Butyrate inhibits LPC-induced endothelial dysfunction by regulating nNOS-produced NO and ROS production","volume":"138\u2013139","author":"Dias","year":"2023","journal-title":"Nitric Oxide Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Beito, M.R., Ashraf, S., Odogwu, D., and Harmancey, R. (2024). Role of Ectopic Olfactory Receptors in the Regulation of the Cardiovascular\u2013Kidney\u2013Metabolic Axis. Life, 14.","DOI":"10.3390\/life14050548"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Janeiro, M.H., Ram\u00edrez, M.J., Milagro, F.I., Mart\u00ednez, J.A., and Solas, M. (2018). Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target. Nutrients, 10.","DOI":"10.3390\/nu10101398"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Hubbard, T., Murray, I., Bisson, W., Lahoti, T.S., Gowda, K., Amin, S.G., Patterson, A.D., and Perdew, G.H. (2015). Adaptation of the human aryl hydrocarbon receptor to sense microbiota-derived indoles. Sci. Rep., 5.","DOI":"10.1038\/srep12689"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12964-023-01373-0","article-title":"Polyamines: Their significance for maintaining health and contributing to diseases","volume":"21","author":"Xuan","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Salari, N., Morddarvanjoghi, F., Abdolmaleki, A., Rasoulpoor, S., Khaleghi, A.A., Hezarkhani, L.A., Shohaimi, S., and Mohammadi, M. (2023). The global prevalence of myocardial infarction: A systematic review and meta-analysis. BMC Cardiovasc. Disord., 23.","DOI":"10.1186\/s12872-023-03231-w"},{"key":"ref_91","first-page":"61","article-title":"The prevalence of myocardial infarction in the elderly: A systematic review and meta-analysis","volume":"20","author":"Rajati","year":"2024","journal-title":"ARYA Atheroscler."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/eurheartj\/ehab581","article-title":"Risk factors for type 1 and type 2 myocardial infarction","volume":"43","author":"Wereski","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cpcardiol.2009.10.002","article-title":"Growing epidemic of coronary heart disease in low- and middle-income countries","volume":"35","author":"Gaziano","year":"2010","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Papadopoulos, P.D., Tsigalou, C., Valsamaki, P.N., Konstantinidis, T.G., Voidarou, C., and Bezirtzoglou, E. (2022). The Emerging Role of the Gut Microbiome in Cardiovascular Disease: Current Knowledge and Perspectives. Biomedicines, 10.","DOI":"10.3390\/biomedicines10050948"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Han, Y., Gong, Z., Sun, G., Xu, J., Qi, C., Sun, W., Jiang, H., Cao, P., and Ju, H. (2021). Dysbiosis of Gut Microbiota in Patients With Acute Myocardial Infarction. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.680101"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Hills, R.D., Pontefract, B.A., Mishcon, H.R., Black, C.A., Sutton, S.C., and Theberge, C.R. (2019). Gut Microbiome: Profound Implications for Diet and Disease. Nutrients, 11.","DOI":"10.3390\/nu11071613"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"112409","DOI":"10.1016\/j.exger.2024.112409","article-title":"Microbiome interactions with different risk factors in development of myocardial infarction","volume":"189","author":"Bijla","year":"2024","journal-title":"Exp. Gerontol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The Role of Gut-Derived Lipopolysaccharides and the Intestinal Barrier in Fatty Liver Diseases","volume":"26","author":"An","year":"2022","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4330\/wjc.v12.i4.110","article-title":"Role of gut microbiota in cardiovascular diseases","volume":"12","author":"Novakovic","year":"2020","journal-title":"World J. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Zhou, X., Li, J., Guo, J., Geng, B., Ji, W., Zhao, Q., Li, J., Liu, X., Liu, J., and Guo, Z. (2018). Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome, 6.","DOI":"10.1186\/s40168-018-0441-4"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Shanmugham, M., Bellanger, S., and Leo, C.H. (2023). Gut-Derived Metabolite, Trimethylamine-N-oxide (TMAO) in Cardio-Metabolic Diseases: Detection, Mechanism, and Potential Therapeutics. Pharmaceuticals, 16.","DOI":"10.3390\/ph16040504"},{"key":"ref_102","first-page":"3164","article-title":"Role of the Gut Bacteria-Derived Metabolite Phenylacetylglutamine in Health and Diseases","volume":"9","author":"Krishnamoorthy","year":"2024","journal-title":"ACS Omega"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lfs.2018.10.063","article-title":"Interaction between gut microbiome and cardiovascular disease","volume":"214","author":"Peng","year":"2018","journal-title":"Life Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e70168","DOI":"10.1002\/mco2.70168","article-title":"Gut Microbiota Dysbiosis: Pathogenesis, Diseases, Prevention, and Therapy","volume":"6","author":"Shen","year":"2025","journal-title":"MedComm"},{"key":"ref_105","first-page":"936","article-title":"The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review","volume":"23","author":"Oktaviono","year":"2023","journal-title":"Biomol. Biomed."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and Excitation-Contraction Coupling in the Heart","volume":"121","author":"Eisner","year":"2017","journal-title":"Circ. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-025-05309-7","article-title":"A review of gut failure as a cause and consequence of critical illness","volume":"29","author":"Soranno","year":"2025","journal-title":"Crit. Care"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/2048872612441582","article-title":"Atherosclerosis, platelets and thrombosis in acute ischaemic heart disease","volume":"1","author":"Badimon","year":"2012","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","article-title":"Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations","volume":"168","author":"Finegold","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Trimarchi, G., Pizzino, F., Paradossi, U., Gueli, I.A., Palazzini, M., Gentile, P., Di Spigno, F., Ammirati, E., Garascia, A., and Tedeschi, A. (2024). Charting the Unseen: How Non-Invasive Imaging Could Redefine Cardiovascular Prevention. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.3390\/jcdd11080245"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s13238-020-00785-9","article-title":"Gut microbes in cardiovascular diseases and their potential therapeutic applications","volume":"12","author":"Jin","year":"2021","journal-title":"Protein Cell"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Alexandrescu, L., Suceveanu, A.P., Stanigut, A.M., Tofolean, D.E., Axelerad, A.D., Iordache, I.E., Herlo, A., Nelson Twakor, A., Nicoara, A.D., and Tocia, C. (2024). Intestinal Insights: The Gut Microbiome\u2019s Role in Atherosclerotic Disease: A Narrative Review. Microorganisms, 12.","DOI":"10.3390\/microorganisms12112341"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.chom.2024.04.017","article-title":"Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2\u03b1 signaling","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Malesza, I.J., Malesza, M., Walkowiak, J., Mussin, N., Walkowiak, D., Aringazina, R., Bartkowiak-Wieczorek, J., and M\u0105dry, E. (2021). High-Fat, Western-Style Diet, Systemic Inflammation, and Gut Microbiota: A Narrative Review. Cells, 10.","DOI":"10.3390\/cells10113164"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"113350","DOI":"10.1016\/j.celrep.2023.113350","article-title":"An obesogenic diet increases atherosclerosis through promoting microbiota dysbiosis-induced gut lymphocyte trafficking into the periphery","volume":"42","author":"Laurans","year":"2023","journal-title":"Cell Rep."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Caradonna, E., Abate, F., Schiano, E., Paparella, F., Ferrara, F., Vanoli, E., Difruscolo, R., Goffredo, V.M., Amato, B., and Setacci, C. (2025). Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health. Metabolites, 15.","DOI":"10.3390\/metabo15040220"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Gui, Y., Zheng, H., and Cao, R.Y. (2022). Foam Cells in Atherosclerosis: Novel Insights Into Its Origins, Consequences, and Molecular Mechanisms. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.845942"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e002767","DOI":"10.1161\/JAHA.115.002767","article-title":"Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-\u03baB","volume":"5","author":"Seldin","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Canyelles, M., Borr\u00e0s, C., Rotllan, N., Tondo, M., Escol\u00e0-Gil, J.C., and Blanco-Vaca, F. (2023). Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24031940"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1897212","DOI":"10.1080\/19490976.2021.1897212","article-title":"The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health","volume":"13","author":"Nogal","year":"2021","journal-title":"Gut Microbes"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"154338","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metab. Clin. Exp."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s13679-023-00503-6","article-title":"Short-Chain Fatty Acids-A Product of the Microbiome and Its Participation in Two-Way Communication on the Microbiome-Host Mammal Line","volume":"12","author":"Lange","year":"2023","journal-title":"Curr. Obes. Rep."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10557-021-07248-1","article-title":"The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases","volume":"37","author":"Strauss","year":"2023","journal-title":"Cardiovasc. Drugs Ther."},{"key":"ref_125","first-page":"30","article-title":"A Review of the Role of Statins in Heart Failure Treatment","volume":"15","author":"Niazi","year":"2020","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_126","first-page":"e74171","article-title":"Efficacy of Different Beta Blockers in Reducing Mortality in Heart-Failure Patients","volume":"16","author":"Roghani","year":"2024","journal-title":"Cureus"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40256-023-00605-5","article-title":"The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines","volume":"23","author":"Alcocer","year":"2023","journal-title":"Am. J. Cardiovasc. Drugs Drugs Devices Other Interv."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.5114\/amsad\/161172","article-title":"Dual antiplatelet therapy with concomitant anticoagulation: Current perspectives on triple therapy","volume":"8","author":"Patail","year":"2023","journal-title":"Arch. Med. Sci. Atheroscler. Dis."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Velidakis, N., Stachteas, P., Gkougkoudi, E., Papadopoulos, C., and Kadoglou, N.P.E. (2024). Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease\u2014A Narrative Clinical Review. Pharmaceuticals, 17.","DOI":"10.3390\/ph17050568"},{"key":"ref_130","first-page":"CD013645","article-title":"Coronary artery bypass surgery versus medical therapy alone for ischaemic heart disease","volume":"2021","author":"Zuo","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s10439-016-1759-3","article-title":"On the Mechanics of Transcatheter Aortic Valve Replacement","volume":"45","author":"Dasi","year":"2017","journal-title":"Ann. Biomed. Eng."},{"key":"ref_132","first-page":"e42616","article-title":"Impact of Lifestyle Modifications on Cardiovascular Health: A Narrative Review","volume":"15","author":"Ghodeshwar","year":"2023","journal-title":"Cureus"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","article-title":"Statin adverse effects: A review of the literature and evidence for a mitochondrial mechanism","volume":"8","author":"Golomb","year":"2008","journal-title":"Am. J. Cardiovasc. Drugs Drugs Devices Other Interv."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Sethi, Y., Patel, N., Kaka, N., Kaiwan, O., Kar, J., Moinuddin, A., Goel, A., Chopra, H., and Cavalu, S. (2023). Precision Medicine and the future of Cardiovascular Diseases: A Clinically Oriented Comprehensive Review. J. Clin. Med., 12.","DOI":"10.3390\/jcm12051799"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Sharifi-Rad, J., Rodrigues, C.F., Sharopov, F., Docea, A.O., Can Karaca, A., Sharifi-Rad, M., Kahveci Kar\u0131ncaoglu, D., G\u00fclseren, G., \u015eenol, E., and Demircan, E. (2020). Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17072326"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"M\u00e9ndez, L., and Medina, I. (2021). Polyphenols and Fish Oils for Improving Metabolic Health: A Revision of the Recent Evidence for Their Combined Nutraceutical Effects. Molecules, 26.","DOI":"10.3390\/molecules26092438"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1017\/jns.2016.41","article-title":"Flavonoids: An overview","volume":"5","author":"Panche","year":"2016","journal-title":"J. Nutr. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Dias, M.C., Pinto, D.C.G.A., and Silva, A.M.S. (2021). Plant Flavonoids: Chemical Characteristics and Biological Activity. Molecules, 26.","DOI":"10.3390\/molecules26175377"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Ullah, A., Munir, S., Badshah, S.L., Khan, N., Ghani, L., Poulson, B.G., Emwas, A.H., and Jaremko, M. (2020). Important Flavonoids and Their Role as a Therapeutic Agent. Molecules, 25.","DOI":"10.3390\/molecules25225243"},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Dre\u021bcanu, G., \u0218tirbu, I., Leoplold, N., Cruceriu, D., Danciu, C., St\u0103nil\u0103, A., F\u0103rca\u0219, A., Borda, I.M., Iuhas, C., and Diaconeasa, Z. (2022). Chemical Structure, Sources and Role of Bioactive Flavonoids in Cancer Prevention: A Review. Plants, 11.","DOI":"10.3390\/plants11091117"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Zahra, M., Abrahamse, H., and George, B.P. (2024). Flavonoids: Antioxidant Powerhouses and Their Role in Nanomedicine. Antioxidants, 13.","DOI":"10.3390\/antiox13080922"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Cium\u0103rnean, L., Milaciu, M.V., Runcan, O., Vesa, \u0218.C., R\u0103chi\u0219an, A.L., Negrean, V., Pern\u00e9, M.G., Donca, V.I., Alexescu, T.G., and Para, I. (2020). The Effects of Flavonoids in Cardiovascular Diseases. Molecules, 25.","DOI":"10.3390\/molecules25184320"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Scioli, M.G., Storti, G., D\u2019Amico, F., Rodr\u00edguez Guzm\u00e1n, R., Centofanti, F., Doldo, E., C\u00e9spedes Miranda, E.M., and Orlandi, A. (2020). Oxidative Stress and New Pathogenetic Mechanisms in Endothelial Dysfunction: Potential Diagnostic Biomarkers and Therapeutic Targets. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061995"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Bellavite, P. (2023). Neuroprotective Potentials of Flavonoids: Experimental Studies and Mechanisms of Action. Antioxidants, 12.","DOI":"10.3390\/antiox12020280"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Mucha, P., Skoczy\u0144ska, A., Ma\u0142ecka, M., Hikisz, P., and Budzisz, E. (2021). Overview of the Antioxidant and Anti-Inflammatory Activities of Selected Plant Compounds and Their Metal Ions Complexes. Molecules, 26.","DOI":"10.3390\/molecules26164886"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Al-Khayri, J.M., Sahana, G.R., Nagella, P., Joseph, B.V., Alessa, F.M., and Al-Mssallem, M.Q. (2022). Flavonoids as Potential Anti-Inflammatory Molecules: A Review. Molecules, 27.","DOI":"10.3390\/molecules27092901"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00204-023-03562-9","article-title":"Reactive oxygen species, toxicity, oxidative stress, and antioxidants: Chronic diseases and aging","volume":"97","author":"Jomova","year":"2023","journal-title":"Arch. Toxicol."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Zhang, W., Zheng, Y., Yan, F., Dong, M., and Ren, Y. (2023). Research progress of quercetin in cardiovascular disease. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1203713"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"111889","DOI":"10.1016\/j.mad.2023.111889","article-title":"Protective effects of apigenin on the brain transcriptome with aging","volume":"217","author":"Cavalier","year":"2024","journal-title":"Mech. Ageing Dev."},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Koz\u0142owska, A., and Szostak-W\u0119gierek, D. (2022). Targeting Cardiovascular Diseases by Flavonols: An Update. Nutrients, 14.","DOI":"10.3390\/nu14071439"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Khan, J., Deb, P.K., Priya, S., Medina, K.D., Devi, R., Walode, S.G., and Rudrapal, M. (2021). Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns. Molecules, 26.","DOI":"10.20944\/preprints202106.0305.v1"},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Yao, J., Peng, T., Shao, C., Liu, Y., Lin, H., and Liu, Y. (2024). The Antioxidant Action of Astragali radix: Its Active Components and Molecular Basis. Molecules, 29.","DOI":"10.3390\/molecules29081691"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Zawawi, N.A., Ahmad, H., Madatheri, R., Fadilah, N.I.M., Maarof, M., and Fauzi, M.B. (2025). Flavonoids as Natural Anti-Inflammatory Agents in the Atopic Dermatitis Treatment. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17020261"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s42826-024-00218-2","article-title":"Flavonoids as therapeutics for myocardial ischemia-reperfusion injury: A comprehensive review on preclinical studies","volume":"40","author":"Verma","year":"2024","journal-title":"Lab. Anim. Res."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/jpp\/rgac093","article-title":"Flavonoids as new regulators of mitochondrial potassium channels: Contribution to cardioprotection","volume":"75","author":"Kampa","year":"2023","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Kulawiak, B., Bednarczyk, P., and Szewczyk, A. (2021). Multidimensional Regulation of Cardiac Mitochondrial Potassium Channels. Cells, 10.","DOI":"10.3390\/cells10061554"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00394-013-0525-7","article-title":"The flavonoid luteolin induces nitric oxide production and arterial relaxation","volume":"53","author":"Si","year":"2014","journal-title":"Eur. J. Nutr."},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Guerrero, L., Castillo, J., Qui\u00f1ones, M., Garcia-Vallv\u00e9, S., Arola, L., Pujadas, G., and Muguerza, B. (2012). Inhibition of angiotensin-converting enzyme activity by flavonoids: Structure-activity relationship studies. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049493"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1146\/annurev.nutr.22.111401.144957","article-title":"Dietary flavonoids: Bioavailability, metabolic effects, and safety","volume":"22","author":"Ross","year":"2002","journal-title":"Annu Rev Nutr."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Ahmed, K.R., Rahman, M.M., Islam, M.N., Fahim, M.M.H., Rahman, M.A., and Kim, B. (2024). Antioxidants activities of phytochemicals perspective modulation of autophagy and apoptosis to treating cancer. Biomed. Pharmacother., 174.","DOI":"10.1016\/j.biopha.2024.116497"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Jubaidi, F.F., Zainalabidin, S., Mariappan, V., and Budin, S.B. (2020). Mitochondrial Dysfunction in Diabetic Cardiomyopathy: The Possible Therapeutic Roles of Phenolic Acids. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176043"},{"key":"ref_162","first-page":"49","article-title":"Flavonoids in myocardial ischemia-reperfusion injury: Therapeutic effects and mechanisms","volume":"13","author":"Jia","year":"2020","journal-title":"Chin. Herb. Med."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3945\/an.111.000893","article-title":"Omega-3 fatty acids EPA and DHA: Health benefits throughout life","volume":"3","author":"Swanson","year":"2012","journal-title":"Adv. Nutr."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"S201","DOI":"10.1017\/S0007114512001596","article-title":"Long chain omega-3 fatty acids and cardiovascular disease: A systematic review","volume":"107","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_165","doi-asserted-by":"crossref","unstructured":"Rauch, B., and Senges, J. (2012). The effects of supplementation with omega-3 polyunsaturated Fatty acids on cardiac rhythm: Anti-arrhythmic, pro-arrhythmic, both or neither? It depends\u2026. Front. Physiol., 3.","DOI":"10.3389\/fphys.2012.00057"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11936-016-0487-1","article-title":"Omega-3 Fatty Acids and Cardiovascular Disease: Are There Benefits?","volume":"18","author":"Bowen","year":"2016","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Rundblad, A., Sandoval, V., Holven, K.B., Ordov\u00e1s, J.M., and Ulven, S.M. (2023). Omega-3 fatty acids and individual variability in plasma triglyceride response: A mini-review. Redox Biol., 63.","DOI":"10.1016\/j.redox.2023.102730"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: Nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Jannas-Vela, S., Espinosa, A., Candia, A.A., Flores-Opazo, M., Pe\u00f1ailillo, L., and Valenzuela, R. (2023). The Role of Omega-3 Polyunsaturated Fatty Acids and Their Lipid Mediators on Skeletal Muscle Regeneration: A Narrative Review. Nutrients, 15.","DOI":"10.3390\/nu15040871"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.prostaglandins.2018.09.005","article-title":"Regulation of platelet function and thrombosis by omega-3 and omega-6 polyunsaturated fatty acids","volume":"139","author":"Adili","year":"2018","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-022-01075-x","article-title":"Role of Omega-3 Fatty Acids in Cardiovascular Disease: The Debate Continues","volume":"25","author":"Sherratt","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Zanetti, M., Grillo, A., Losurdo, P., Panizon, E., Mearelli, F., Cattin, L., Barazzoni, R., and Carretta, R. (2015). Omega-3 Polyunsaturated Fatty Acids: Structural and Functional Effects on the Vascular Wall. BioMed Res. Int., 2015.","DOI":"10.1155\/2015\/791978"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1017\/S1368980017003834","article-title":"Fish consumption and risk of all-cause and cardiovascular mortality: A dose-response meta-analysis of prospective observational studies","volume":"21","author":"Jayedi","year":"2018","journal-title":"Public Health Nutr."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Moreno, C., Mac\u00edas, A., Prieto, A., de la Cruz, A., Gonz\u00e1lez, T., and Valenzuela, C. (2012). Effects of n-3 Polyunsaturated Fatty Acids on Cardiac Ion Channels. Front. Physiol., 3.","DOI":"10.3389\/fphys.2012.00245"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Salehi, B., Mishra, A.P., Nigam, M., Sener, B., Kilic, M., Sharifi-Rad, M., Fokou, P.V.T., Martins, N., and Sharifi-Rad, J. (2018). Resveratrol: A Double-Edged Sword in Health Benefits. Biomedicines, 6.","DOI":"10.3390\/biomedicines6030091"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1186\/s12967-023-04361-7","article-title":"Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease","volume":"21","author":"Yan","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"16102","DOI":"10.3390\/molecules191016102","article-title":"Resveratrol and endothelial nitric oxide","volume":"19","author":"Xia","year":"2014","journal-title":"Molecules"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., and He, J. (2021). Anti-Inflammatory Action and Mechanisms of Resveratrol. Molecules, 26.","DOI":"10.3390\/molecules26010229"},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Salazar, J., Pirela, D., Nava, M., Castro, A., Angarita, L., Parra, H., Dur\u00e1n-Ag\u00fcero, S., Rojas-G\u00f3mez, D.M., Galb\u00e1n, N., and A\u00f1ez, R. (2022). Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23063133"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"H1375","DOI":"10.1152\/ajpheart.00053.2015","article-title":"The role of sirtuins in cardiac disease","volume":"309","author":"Matsushima","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.bbadis.2014.10.016","article-title":"Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases","volume":"1852","author":"Zordoky","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_182","doi-asserted-by":"crossref","unstructured":"Bonnefont-Rousselot, D. (2016). Resveratrol and Cardiovascular Diseases. Nutrients, 8.","DOI":"10.3390\/nu8050250"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Cox, F.F., Misiou, A., Vierkant, A., Ale-Agha, N., Grandoch, M., Haendeler, J., and Altschmied, J. (2022). Protective Effects of Curcumin in Cardiovascular Diseases-Impact on Oxidative Stress and Mitochondria. Cells, 11.","DOI":"10.3390\/cells11030342"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"M\u0142ynarska, E., Hajdys, J., Czarnik, W., Fularski, P., Leszto, K., Majchrowicz, G., Lisi\u0144ska, W., Rysz, J., and Franczyk, B. (2024). The Role of Antioxidants in the Therapy of Cardiovascular Diseases-A Literature Review. Nutrients, 16.","DOI":"10.3390\/nu16162587"},{"key":"ref_185","doi-asserted-by":"crossref","unstructured":"Singh, L., Sharma, S., Xu, S., Tewari, D., and Fang, J. (2021). Curcumin as a Natural Remedy for Atherosclerosis: A Pharmacological Review. Molecules, 26.","DOI":"10.20944\/preprints202105.0735.v1"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Wang, A.J., Tang, Y., Zhang, J., Wang, B.J., Xiao, M., Lu, G., Li, J., Liu, Q., Guo, Y., and Gu, J. (2022). Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2. Redox Biol., 52.","DOI":"10.1016\/j.redox.2022.102310"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"3906043","DOI":"10.1155\/2023\/3906043","article-title":"Curcumin Improves Diabetic Cardiomyopathy by Inhibiting Pyroptosis through AKT\/Nrf2\/ARE Pathway","volume":"2023","author":"Wei","year":"2023","journal-title":"Mediat. Inflamm."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Bahrami, A., Montecucco, F., Carbone, F., and Sahebkar, A. (2021). Effects of Curcumin on Aging: Molecular Mechanisms and Experimental Evidence. BioMed Res. Int., 2021.","DOI":"10.1155\/2021\/8972074"},{"key":"ref_189","doi-asserted-by":"crossref","unstructured":"Sunagawa, Y., Funamoto, M., Shimizu, K., Shimizu, S., Sari, N., Katanasaka, Y., Miyazaki, Y., Kakeya, H., Hasegawa, K., and Morimoto, T. (2021). Curcumin, an Inhibitor of p300-HAT Activity, Suppresses the Development of Hypertension-Induced Left Ventricular Hypertrophy with Preserved Ejection Fraction in Dahl Rats. Nutrients, 13.","DOI":"10.3390\/nu13082608"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.18632\/aging.101149","article-title":"Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress","volume":"9","author":"Strahler","year":"2017","journal-title":"Aging"},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Nurcahyanti, A.D.R., Cokro, F., Wulanjati, M.P., Mahmoud, M.F., Wink, M., and Sobeh, M. (2022). Curcuminoids for Metabolic Syndrome: Meta-Analysis Evidences Toward Personalized Prevention and Treatment Management. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.891339"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Ro\u015fian, \u015e.H., Boarescu, I., and Boarescu, P.-M. (2025). Antioxidant and Anti-Inflammatory Effects of Bioactive Compounds in Atherosclerosis. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26031379"},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Rabanal-Ruiz, Y., Llanos-Gonz\u00e1lez, E., and Alcain, F.J. (2021). The Use of Coenzyme Q10 in Cardiovascular Diseases. Antioxidants, 10.","DOI":"10.3390\/antiox10050755"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000360101","article-title":"Coenzyme q10 therapy","volume":"5","author":"Cordero","year":"2014","journal-title":"Mol. Syndromol."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","article-title":"Nitric Oxide and Endothelial Dysfunction","volume":"36","author":"Cyr","year":"2020","journal-title":"Crit. Care Clin."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: Results from Q-SYMBIO: A randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Fail."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2174\/1573403X14666180416115428","article-title":"Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem","volume":"14","author":"Zozina","year":"2018","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_198","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez-Rivero, J.M., Pastor-Maldonado, C.J., de la Mata, M., Villanueva-Paz, M., Povea-Cabello, S., \u00c1lvarez-C\u00f3rdoba, M., Villal\u00f3n-Garc\u00eda, I., Su\u00e1rez-Carrillo, A., Talaver\u00f3n-Rey, M., and Munuera, M. (2019). Atherosclerosis and Coenzyme Q10. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20205195"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40200-014-0081-6","article-title":"Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: A randomized, double blind, placebo-controlled trial","volume":"13","author":"Zahedi","year":"2014","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Martelli, A., Testai, L., Colletti, A., and Cicero, A.F.G. (2020). Coenzyme Q10: Clinical Applications in Cardiovascular Diseases. Antioxidants, 9.","DOI":"10.3390\/antiox9040341"},{"key":"ref_201","doi-asserted-by":"crossref","unstructured":"Dohlmann, T.L., Kuhlman, A.B., Morville, T., Dahl, M., Asping, M., Orlando, P., Silvestri, S., Tiano, L., Helge, J.W., and Dela, F. (2022). Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial. Antioxidants, 11.","DOI":"10.3390\/antiox11091698"},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Mantle, D., and Dybring, A. (2020). Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism. Antioxidants, 9.","DOI":"10.3390\/antiox9050386"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Yurika, N., Montuori, E., and Lauritano, C. (2024). Marine Microalgal Products with Activities against Age-Related Cardiovascular Diseases. Mar. Drugs, 22.","DOI":"10.3390\/md22050229"},{"key":"ref_204","doi-asserted-by":"crossref","unstructured":"Nishida, Y., Berg, P.C., Shakersain, B., Hecht, K., Takikawa, A., Tao, R., Kakuta, Y., Uragami, C., Hashimoto, H., and Misawa, N. (2023). Astaxanthin: Past, Present, and Future. Mar. Drugs, 21.","DOI":"10.3390\/md21100514"},{"key":"ref_205","doi-asserted-by":"crossref","unstructured":"Akram, W., Rihan, M., Ahmed, S., Arora, S., Ahmad, S., and Vashishth, R. (2023). Marine-Derived Compounds Applied in Cardiovascular Diseases: Submerged Medicinal Industry. Mar. Drugs, 21.","DOI":"10.3390\/md21030193"},{"key":"ref_206","doi-asserted-by":"crossref","unstructured":"Nagahawatta, D.P., Liyanage, N.M., Jayawardena, T.U., and Jeon, Y.J. (2024). Marine Polyphenols in Cardiovascular Health: Unraveling Structure-Activity Relationships, Mechanisms, and Therapeutic Implications. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25158419"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.3390\/md13116838","article-title":"Seaweeds as Preventive Agents for Cardiovascular Diseases: From Nutrients to Functional Foods","volume":"13","author":"Cardoso","year":"2015","journal-title":"Mar. Drugs"},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Lamminp\u00e4\u00e4, I., Amedei, A., and Parolini, C. (2024). Effects of Marine-Derived Components on Cardiovascular Disease Risk Factors and Gut Microbiota Diversity. Mar. Drugs, 22.","DOI":"10.20944\/preprints202410.2395.v1"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Han, Y., Kim, D.H., and Pack, S.P. (2024). Marine-Derived Bioactive Ingredients in Functional Foods for Aging: Nutritional and Therapeutic Perspectives. Mar. Drugs, 22.","DOI":"10.3390\/md22110496"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Olas, B. (2020). Probiotics, Prebiotics and Synbiotics-A Promising Strategy in Prevention and Treatment of Cardiovascular Diseases?. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21249737"},{"key":"ref_211","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Yerena, A., de Santisteban Villaplana, V., Badimon, L., Vilahur, G., and Padro, T. (2025). Probiotics: A Potential Strategy for Preventing and Managing Cardiovascular Disease. Nutrients, 17.","DOI":"10.3390\/nu17010052"},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Yang, F., Gao, R., Luo, X., Liu, R., and Xiong, D. (2023). Berberine influences multiple diseases by modifying gut microbiota. Front. Nutr., 10.","DOI":"10.3389\/fnut.2023.1187718"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40495-016-0070-1","article-title":"Therapeutic Potential and Mechanisms of Berberine in Cardiovascular Disease","volume":"2","author":"Zhang","year":"2016","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Deng, B., Tao, L., and Wang, Y. (2022). Natural products against inflammation and atherosclerosis: Targeting on gut microbiota. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.997056"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Wang, X., Qi, Y., and Zheng, H. (2022). Dietary Polyphenol, Gut Microbiota, and Health Benefits. Antioxidants, 11.","DOI":"10.3390\/antiox11061212"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"3946320241250286","DOI":"10.1177\/03946320241250286","article-title":"Evaluation of the protective effect of coenzyme Q10 on hepatotoxicity caused by acute phosphine poisoning","volume":"38","author":"Hami","year":"2024","journal-title":"Int. J. ImmunopathoL. Pharmacol."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Aghababaei, F., and Hadidi, M. (2023). Recent Advances in Potential Health Benefits of Quercetin. Pharmaceuticals, 16.","DOI":"10.3390\/ph16071020"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Mi, W., Hu, Z., Xu, L., Bian, X., Lian, W., Yin, S., Zhao, S., Gao, W., Guo, C., and Shi, T. (2022). Quercetin positively affects gene expression profiles and metabolic pathway of antibiotic-treated mouse gut microbiota. Front. Microbiol., 13.","DOI":"10.3389\/fmicb.2022.983358"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"2390136","DOI":"10.1080\/19490976.2024.2390136","article-title":"Quercetin activates energy expenditure to combat metabolic syndrome through modulating gut microbiota-bile acids crosstalk in mice","volume":"16","author":"Zhu","year":"2024","journal-title":"Gut Microbes"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.pan.2018.08.001","article-title":"Quercetin protects against intestinal barrier disruption and inflammation in acute necrotizing pancreatitis through TLR4\/MyD88\/p38 MAPK and ERS inhibition","volume":"18","author":"Junyuan","year":"2018","journal-title":"Pancreatology"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1039\/C7FO01383C","article-title":"A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota","volume":"8","author":"Zhao","year":"2017","journal-title":"Food Funct."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2174\/1389557521666210105122841","article-title":"Ferulic Acid and Cardiovascular Health: Therapeutic and Preventive Potential","volume":"21","author":"Dejani","year":"2021","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"d\u2019Angelo, M., Castelli, V., Tupone, M.G., Catanesi, M., Antonosante, A., Dominguez-Benot, R., Ippoliti, R., Cimini, A.M., and Benedetti, E. (2019). Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215422"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"2300065","DOI":"10.1002\/elsc.202300065","article-title":"Flavonoids, gut microbiota, and host lipid metabolism","volume":"24","author":"Zhou","year":"2023","journal-title":"Eng. Life Sci."},{"key":"ref_225","first-page":"524","article-title":"Role of apigenin in targeting metabolic syndrome: A systematic review","volume":"27","author":"Javadi","year":"2024","journal-title":"Iran. J. Basic Med. Sci."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"El-Saadony, M.T., Yang, T., Korma, S.A., Sitohy, M., Abd El-Mageed, T.A., Selim, S., Al Jaouni, S.K., Salem, H.M., Mahmmod, Y., and Soliman, S.M. (2023). Impacts of turmeric and its principal bioactive curcumin on human health: Pharmaceutical, medicinal, and food applications: A comprehensive review. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.1040259"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"e1425085","DOI":"10.1080\/21688370.2018.1425085","article-title":"Curcumin-mediated regulation of intestinal barrier function: The mechanism underlying its beneficial effects","volume":"6","author":"Ghosh","year":"2018","journal-title":"Tissue Barriers"},{"key":"ref_228","doi-asserted-by":"crossref","unstructured":"Zarfeshany, A., Asgary, S., and Javanmard, S.H. (2014). Potent health effects of pomegranate. Adv. Biomed. Res., 3.","DOI":"10.4103\/2277-9175.129371"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"382763","DOI":"10.1155\/2012\/382763","article-title":"Pomegranate Protection against Cardiovascular Diseases","volume":"2012","author":"Aviram","year":"2012","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_230","doi-asserted-by":"crossref","unstructured":"Festa, J., Hussain, A., Al-Hareth, Z., Singh, H., and Da Boit, M. (2023). Anthocyanins and Vascular Health: A Matter of Metabolites. Foods, 12.","DOI":"10.3390\/foods12091796"},{"key":"ref_231","doi-asserted-by":"crossref","unstructured":"Xiong, H.H., Lin, S.Y., Chen, L.L., Ouyang, K.H., and Wang, W.J. (2023). The Interaction between Flavonoids and Intestinal Microbes: A Review. Foods, 12.","DOI":"10.3390\/foods12020320"},{"key":"ref_232","doi-asserted-by":"crossref","unstructured":"Zhong, H., Xu, J., Yang, M., Hussain, M., Liu, X., Feng, F., and Guan, R. (2023). Protective Effect of Anthocyanins against Neurodegenerative Diseases through the Microbial-Intestinal-Brain Axis: A Critical Review. Nutrients, 15.","DOI":"10.3390\/nu15030496"},{"key":"ref_233","doi-asserted-by":"crossref","unstructured":"Mozos, I., Flangea, C., Vlad, D.C., Gug, C., Mozos, C., Stoian, D., Luca, C.T., Horba\u0144czuk, J.O., Horba\u0144czuk, O.K., and Atanasov, A.G. (2021). Effects of Anthocyanins on Vascular Health. Biomolecules, 11.","DOI":"10.3390\/biom11060811"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/acs.jafc.2c05879","article-title":"Anthocyanins as Promising Molecules Affecting Energy Homeostasis, Inflammation, and Gut Microbiota in Type 2 Diabetes with Special Reference to Impact of Acylation","volume":"71","author":"Chen","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.numecd.2010.04.011","article-title":"Bilberry anthocyanin-rich extract alters expression of genes related to atherosclerosis development in aorta of apo E-deficient mice","volume":"22","author":"Mauray","year":"2012","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.atherosclerosis.2016.01.025","article-title":"microRNAs in lipoprotein metabolism and cardiometabolic disorders","volume":"246","author":"Rotllan","year":"2016","journal-title":"Atherosclerosis"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Chihomvu, P., Ganesan, A., Gibbons, S., Woollard, K., and Hayes, M.A. (2024). Phytochemicals in Drug Discovery-A Confluence of Tradition and Innovation. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202406.0927.v2"},{"key":"ref_238","doi-asserted-by":"crossref","unstructured":"Roy, A., Khan, A., Ahmad, I., Alghamdi, S., Rajab, B.S., Babalghith, A.O., Alshahrani, M.Y., Islam, S., and Islam, M.R. (2022). Flavonoids a Bioactive Compound from Medicinal Plants and Its Therapeutic Applications. BioMed Res. Int., 2022.","DOI":"10.1155\/2022\/5445291"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"1559325819852243","DOI":"10.1177\/1559325819852243","article-title":"Cardioprotective Potential of Plant-Derived Molecules: A Scientific and Medicinal Approach","volume":"17","author":"Shah","year":"2019","journal-title":"Dose-Response A Publ. Int. Hormesis Soc."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Tungmunnithum, D., Thongboonyou, A., Pholboon, A., and Yangsabai, A. (2018). Flavonoids and Other Phenolic Compounds from Medicinal Plants for Pharmaceutical and Medical Aspects: An Overview. Medicines, 5.","DOI":"10.3390\/medicines5030093"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Khatiwada, N., and Hong, Z. (2024). Potential Benefits and Risks Associated with the Use of Statins. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16020214"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"e70101","DOI":"10.1002\/fsn3.70101","article-title":"Dietary Phytochemicals in Health and Disease: Mechanisms, Clinical Evidence, and Applications-A Comprehensive Review","volume":"13","author":"Hossain","year":"2025","journal-title":"Food Sci. Nutr."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"100695","DOI":"10.1016\/j.phyplu.2024.100695","article-title":"Role of phytochemicals in cardiovascular disease management: Insights into mechanisms, efficacy, and clinical application","volume":"5","author":"Alum","year":"2025","journal-title":"Phytomed. Plus"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Li, K.X., Wang, Z.C., Machuki, J.O., Li, M.Z., Wu, Y.J., Niu, M.K., Yu, K.Y., Lu, Q.B., and Sun, H.J. (2022). Benefits of Curcumin in the Vasculature: A Therapeutic Candidate for Vascular Remodeling in Arterial Hypertension and Pulmonary Arterial Hypertension?. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.848867"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Chaachouay, N. (2025). Synergy, Additive Effects, and Antagonism of Drugs with Plant Bioactive Compounds. Drugs Drug Candidates, 4.","DOI":"10.3390\/ddc4010004"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"10135","DOI":"10.18632\/oncotarget.20807","article-title":"Metformin and berberine, two versatile drugs in treatment of common metabolic diseases","volume":"9","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_247","doi-asserted-by":"crossref","unstructured":"Dagher, O., Mury, P., Thorin-Trescases, N., Noly, P.E., Thorin, E., and Carrier, M. (2021). Therapeutic Potential of Quercetin to Alleviate Endothelial Dysfunction in Age-Related Cardiovascular Diseases. Front. Cardiovasc. Med., 8.","DOI":"10.3389\/fcvm.2021.658400"},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Breuss, J.M., Atanasov, A.G., and Uhrin, P. (2019). Resveratrol and Its Effects on the Vascular System. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20071523"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.metabol.2008.01.037","article-title":"Combination of simvastatin with berberine improves the lipid-lowering efficacy","volume":"57","author":"Kong","year":"2008","journal-title":"Metab. Clin. Exp."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.yjmcc.2006.10.018","article-title":"Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat","volume":"42","author":"Penumathsa","year":"2007","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Carrillo-Martinez, E.J., Flores-Hern\u00e1ndez, F.Y., Salazar-Montes, A.M., Nario-Chaidez, H.F., and Hern\u00e1ndez-Ortega, L.D. (2024). Quercetin, a Flavonoid with Great Pharmacological Capacity. Molecules, 29.","DOI":"10.20944\/preprints202402.0029.v1"},{"key":"ref_252","first-page":"1921","article-title":"In-vitro Synergistic Effect of Metformin and Berberine on High Glucose-induced Lipogenesis","volume":"18","author":"Namvarjah","year":"2019","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00005344-200112000-00009","article-title":"Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase","volume":"38","author":"Kang","year":"2001","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Zhao, X., Cheng, T., Xia, H., Yang, Y., and Wang, S. (2024). Effects of Garlic on Glucose Parameters and Lipid Profile: A Systematic Review and Meta-Analysis on Randomized Controlled Trials. Nutrients, 16.","DOI":"10.3390\/nu16111692"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Wang, H., Chen, Y., Wang, L., Liu, Q., Yang, S., and Wang, C. (2023). Advancing herbal medicine: Enhancing product quality and safety through robust quality control practices. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1265178"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2147\/COPD.S244942","article-title":"Comparing Randomized Controlled Trials and Real-World Studies in Chronic Obstructive Pulmonary Disease Pharmacotherapy","volume":"15","author":"Tashkin","year":"2020","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1111\/bcp.15242","article-title":"Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response","volume":"88","author":"Gross","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_258","doi-asserted-by":"crossref","unstructured":"Resurreccion, E.P., and Fong, K.W. (2022). The Integration of Metabolomics with Other Omics: Insights into Understanding Prostate Cancer. Metabolites, 12.","DOI":"10.3390\/metabo12060488"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s44337-024-00177-6","article-title":"The use of quality control parameters in the evaluation of herbal drugs. A review","volume":"1","author":"Edo","year":"2024","journal-title":"Discov. Med."},{"key":"ref_260","doi-asserted-by":"crossref","unstructured":"Vaou, N., Stavropoulou, E., Voidarou, C., Tsigalou, C., and Bezirtzoglou, E. (2021). Towards Advances in Medicinal Plant Antimicrobial Activity: A Review Study on Challenges and Future Perspectives. Microorganisms, 9.","DOI":"10.3390\/microorganisms9102041"},{"key":"ref_261","doi-asserted-by":"crossref","unstructured":"Avigan, M.I., Mozersky, R.P., and Seeff, L.B. (2016). Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030331"},{"key":"ref_262","first-page":"492","article-title":"Regulatory perspectives of combination products","volume":"10","author":"Tian","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"2582463","DOI":"10.1155\/2017\/2582463","article-title":"Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases","volume":"2017","author":"Ondieki","year":"2017","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/157488406776872550","article-title":"Effect of grapefruit juice in relation to human pharmacokinetic study","volume":"1","author":"Uno","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12248-009-9146-8","article-title":"Herb-drug interactions with St John\u2019s wort (Hypericum perforatum): An update on clinical observations","volume":"11","author":"Borrelli","year":"2009","journal-title":"AAPS J."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"957362","DOI":"10.1155\/2014\/957362","article-title":"Updates on the clinical evidenced herb-warfarin interactions","volume":"2014","author":"Ge","year":"2014","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41569-021-00549-w","article-title":"Pharmacogenetics to guide cardiovascular drug therapy","volume":"18","author":"Duarte","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Santhiravel, S., Bekhit, A.E.A., Mendis, E., Jacobs, J.L., Dunshea, F.R., Rajapakse, N., and Ponnampalam, E.N. (2022). The Impact of Plant Phytochemicals on the Gut Microbiota of Humans for a Balanced Life. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158124"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4264\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:24:47Z","timestamp":1760030687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/9\/4264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":268,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijms26094264"],"URL":"https:\/\/doi.org\/10.3390\/ijms26094264","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]}}}